A yeast chemical genetic screen identifies inhibitors of human telomerase

Chemistry and Biology

Volumn 20, Issue 3, 2013, Pages 333-340

  Wong, Lai Hong ^a   Unciti Broceta, Asier ^b   Spitzer, Michaela ^a   White, Rachel ^a   Tyers, Mike ^a,c   Harrington, Lea ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD 11359; RJC 00417; SEW 05920; SPB 03924; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; GENETIC SCREENING; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; MOLECULAR LIBRARY; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

CATALYTIC DOMAIN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PHENOTYPE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TELOMERASE; TELOMERE-BINDING PROTEINS;

EUKARYOTA;

EID: 84875423336     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.12.008     Document Type: Article

References (35)

1. C. Autexier, R. Pruzan, W.D. Funk, and C.W. Greider Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA EMBO J. 15 1996 5928 5935
2. F. Bachand, and C. Autexier Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae J. Biol. Chem. 274 1999 38027 38031
3. A. Bah, F. Bachand, E. Clair, C. Autexier, and R.J. Wellinger Humanized telomeres and an attempt to express a functional human telomerase in yeast Nucleic Acids Res. 32 2004 1917 1927
4. S.S. Banik, C. Guo, A.C. Smith, S.S. Margolis, D.A. Richardson, C.A. Tirado, and C.M. Counter C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity Mol. Cell. Biol. 22 2002 6234 6246
5. T.L. Beattie, W. Zhou, M.O. Robinson, and L. Harrington Reconstitution of human telomerase activity in vitro Curr. Biol. 8 1998 177 180
6. T.L. Beattie, W. Zhou, M.O. Robinson, and L. Harrington Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding Mol. Biol. Cell 11 2000 3329 3340
7. D. Burke, D. Dawson, and T. Stearns Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual 2000 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
8. O. Ceyhan, K. Birsoy, and C.S. Hoffman Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen Chem. Biol. 19 2012 155 163
9. F. d'Adda di Fagagna, S.H. Teo, and S.P. Jackson Functional links between telomeres and proteins of the DNA-damage response Genes Dev. 18 2004 1781 1799
10. K. Damm, U. Hemmann, P. Garin-Chesa, N. Hauel, I. Kauffmann, H. Priepke, C. Niestroj, C. Daiber, B. Enenkel, and B. Guilliard A highly selective telomerase inhibitor limiting human cancer cell proliferation EMBO J. 20 2001 6958 6968
11. H. El-Daly, M. Kull, S. Zimmermann, M. Pantic, C.F. Waller, and U.M. Martens Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532 Blood 105 2005 1742 1749
12. S.K. Evans, and V. Lundblad Est1 and Cdc13 as comediators of telomerase access Science 286 1999 117 120
13. R.D. Gietz, and R.A. Woods Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method Methods Enzymol. 350 2002 87 96
14. J. Gomez-Millan, E.M. Goldblatt, S.M. Gryaznov, M.S. Mendonca, and B.S. Herbert Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells Int. J. Radiat. Oncol. Biol. Phys. 67 2007 897 905
15. P.D. Good, and D.R. Engelke Yeast expression vectors using RNA polymerase III promoters Gene 151 1994 209 214
16. G. Griffioen, H. Duhamel, N. Van Damme, K. Pellens, P. Zabrocki, C. Pannecouque, F. van Leuven, J. Winderickx, and S. Wera A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential Biochim. Biophys. Acta 1762 2006 312 318
17. C.B. Harley Telomerase and cancer therapeutics Nat. Rev. Cancer 8 2008 167 179
18. L. Harrington, W. Zhou, T. McPhail, R. Oulton, D.S. Yeung, V. Mar, M.B. Bass, and M.O. Robinson Human telomerase contains evolutionarily conserved catalytic and structural subunits Genes Dev. 11 1997 3109 3115
19. H. Ishizaki, M. Spitzer, J. Wildenhain, C. Anastasaki, Z. Zeng, S. Dolma, M. Shaw, E. Madsen, J. Gitlin, and R. Marais Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation Dis. Model Mech. 3 2010 639 651
20. S. Makovets, I. Herskowitz, and E.H. Blackburn Anatomy and dynamics of DNA replication fork movement in yeast telomeric regions Mol. Cell. Biol. 24 2004 4019 4031
21. R. Oulton, and L. Harrington A human telomerase-associated nuclease Mol. Biol. Cell 15 2004 3244 3256
22. E. Pascolo, C. Wenz, J. Lingner, N. Hauel, H. Priepke, I. Kauffmann, P. Garin-Chesa, W.J. Rettig, K. Damm, and A. Schnapp Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate J. Biol. Chem. 277 2002 15566 15572
23. M. Penazzato, and C. Giaquinto Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children Drugs 71 2011 2131 2149
24. E. Perkins, D. Sun, A. Nguyen, S. Tulac, M. Francesco, H. Tavana, H. Nguyen, S. Tugendreich, P. Barthmaier, and J. Couto Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast Cancer Res. 61 2001 4175 4183
25. A. Röth, C.B. Harley, and G.M. Baerlocher Imetelstat (GRN163L) - telomerase-based cancer therapy Recent Results Cancer Res. 184 2010 221 234
26. J. Rouse Esc4p, a new target of Mec1p (ATR), promotes resumption of DNA synthesis after DNA damage EMBO J. 23 2004 1188 1197
27. L.L. Sandell, and V.A. Zakian Loss of a yeast telomere: arrest, recovery, and chromosome loss Cell 75 1993 729 739
28. D.C. Sealey, L. Zheng, M.A. Taboski, J. Cruickshank, M. Ikura, and L.A. Harrington The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization Nucleic Acids Res. 38 2010 2019 2035
29. A. Stepanov, K.C. Nitiss, G. Neale, and J.L. Nitiss Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors Mol. Pharmacol. 74 2008 423 431
30. M.A. Taboski, D.C. Sealey, J. Dorrens, C. Tayade, D.H. Betts, and L. Harrington Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis Cell Rep. 1 2012 91 98
31. B.J. Thomas, and R. Rothstein The genetic control of direct-repeat recombination in Saccharomyces: the effect of rad52 and rad1 on mitotic recombination at GAL10, a transcriptionally regulated gene Genetics 123 1989 725 738
32. O. Uziel, E. Beery, V. Dronichev, K. Samocha, S. Gryaznov, L. Weiss, S. Slavin, M. Kushnir, Y. Nordenberg, and C. Rabinowitz Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms PLoS ONE 5 2010 e9132
33. R.J. Ward, and C. Autexier Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment Mol. Pharmacol. 68 2005 779 786
34. J. Warringer, and A. Blomberg Automated screening in environmental arrays allows analysis of quantitative phenotypic profiles in Saccharomyces cerevisiae Yeast 20 2003 53 67
35. X. Zhao, E.G. Muller, and R. Rothstein A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools Mol. Cell 2 1998 329 340